AllPennyStocks.com DFTX Stock Climbs As High As 12% On ‘Unprecedented’ Anxiety Data For LSD-Based Drug
This section contains press releases and other materials from third parties (including paid content). AllPennyStocks.com has not reviewed this content. Please see our disclaimer.

DFTX Stock Climbs As High As 12% On ‘Unprecedented’ Anxiety Data For LSD-Based Drug

The company said that the Panorama trial of DT120, a fast-dissolving tablet form of the psychedelic drug lysergide, or LSD, met its main goal in adults with generalized anxiety disorder.

Other Penny Stock Movers

This Critical Minerals Explorer Just Found Where to Look Next
Maiden Drill Campaign at Onuki Zone Concludes Under Sumitomo Earn-In
High-Grade 190 g/t Gold Grab Sample Highlights Manitoba Quartz Vein Expansion
Most Popular
{{ index + 1 }}


Back to Top